…of the agreement, research teams from both organisations will collaborate to develop follow-on technologies to support the purification of viruses and viral vectors for research and clinical use. One of…

…overcome the key challenges of drug design and select lead candidates with the best chances of clinical success. The platform evaluates specificity, functionality, safety and manufacturability of antibodies to reduce…

…service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization of products, today announces that Stefan Fraenkel, Executive…

…4.0 software, which provides greater flexibility and customisation for this growing industry. Thermo Fisher Scientific said its partnership with provider of sample preparation technologies for protein-based clinical research, Evosep, recently…

…compound, ETX001, to enhance the activity of TMEM16A in human bronchial epithelial cells from CF patients, increasing epithelial fluid secretion and mucus clearance providing the first pre-clinical proof of principle…

…and ERAP2 modulators.” Grey Wolf is expanding efforts around ERAP2 for two reasons. First, clinical data continues to demonstrate that tumors which are more visible to the immune system show…

…support the evaluation of mRNA-1273 in clinical efficacy trials. They also explain how their prior research on a candidate MERS-CoV vaccine paved the way for a rapid response to the…

…need for new in vitro tools that better predict clinical outcomes, it is a privilege to be working for a company whose potential to make a difference is so great.”…

…safety, lower attrition rates in clinical studies, and a faster time to market to help patients with severe diseases worldwide through novel therapies,” said Dr. Friedrich von Bohlen, Molecular Health…

…to market. Significant advances have been made in recent years in the use of cell and gene therapies in disease areas with unmet clinical needs. However, reliable methods are still…

This a new clinical development partnership to progress a therapeutic DNA vaccine, TGL-100, into an early phase clinical trial targeting head and neck squamous cell carcinoma (HNSCC) HNSCC is the…

…control this pandemic,” said NIAID Director Anthony Fauci. “Results from early-stage clinical testing indicate the investigational mRNA-1273 vaccine is safe and immunogenic, supporting the initiation of a Phase 3 clinical…

…clinical consumables, clinical trials supplies, products of human origin (blood and transplant items), and vaccines and countermeasures. The government is asking suppliers to put in place “flexible mitigation and readiness…

…sizes, from non-profit organizations and early stage startups to clinical stage biotechnology and large pharmaceutical companies, in their journey to develop much-needed novel therapeutic products using our expression platform.” Dr….

…development of the vaccine, including clinical trials, with the remainder used for manufacturing scale-up and delivery of an initial 100 million doses of the vaccine. Sanofi will receive the majority…

This will explore clinical trials with IMM-101, in combination with other treatments, in difficult to treat cancers, with a particular focus on epithelial cancers such as pancreatic cancer and sarcoma….